Coherus BioSciences Logo

Coherus BioSciences

Innovative immunotherapies for cancer

biotechnology
biosimilars
Immuno-oncology

About Coherus BioSciences

Coherus BioSciences is a commercial-stage biopharmaceutical company dedicated to the research, development, and commercialization of innovative immunotherapies to treat cancer. We also focus on the commercialization of our FDA-approved therapeutics. Our goal is to build a leading oncology company supported by in-house expertise and a robust infrastructure from our diversified portfolio of FDA-approved biosimilar products. Explore career opportunities with us and join a highly innovative and exciting company.

Overview

  • Website
  • LinkedIn
  • Twitter
  • 201-500 employees
  • Founded in 2010
  • 4 active jobs
  • Hiring in:
    • 🇺🇸 United States